Top Stories
Latest Coverage
Colorectal Cancer Immunotherapy: How MSI-H/dMMR Helps Identify Patients Who May Benefit
The treatment landscape for colorectal cancer is changing rapidly. With advances in precision medicine, treatment dec...
The treatment landscape for colorectal cancer is changing rapidly. With advances in precision medicine, treatment dec...
What Are the Targeted Therapy Drugs for Liver Cancer? Common Targeted Drugs and Treatment Options
Liver cancer is one of the most common malignant tumors worldwide. Among them, hepatocellular carcinoma (HCC) is the ...
Liver cancer is one of the most common malignant tumors worldwide. Among them, hepatocellular carcinoma (HCC) is the ...
A New Breakthrough in Colorectal Cancer ADC Therapy: Trastuzumab Rezetecan Approved for HER2-Positive Colorectal Cancer in China
For patients with HER2-positive advanced colorectal cancer (CRC), treatment options have remained limited after failu...
For patients with HER2-positive advanced colorectal cancer (CRC), treatment options have remained limited after failu...
Gastric Cancer Treatment Is No Longer Just About Chemotherapy: How Precision Medicine Is Shaping the Future | A Comprehensive Guide to HER2, CLDN18.2, and FGFR2b
Gastric cancer remains one of the most common malignancies worldwide and is a leading cause of cancer-related mortali...
Gastric cancer remains one of the most common malignancies worldwide and is a leading cause of cancer-related mortali...
From Targeted Therapy to the ADC Era: Which Lung Cancer Patients Are Suitable for TROP2 ADC Therapy?
Lung cancer remains one of the leading causes of cancer incidence and mortality worldwide. In recent years, advances ...
Lung cancer remains one of the leading causes of cancer incidence and mortality worldwide. In recent years, advances ...
